文献速递泌尿生殖妇产影像腹部CT

对比增强双能光谱CT鉴别交界性与恶性上皮性卵巢肿瘤的应用

Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
PubMed 文献 · Clin Radiol · 2021-05-28

回顾性分析60例卵巢上皮性肿瘤患者(交界性26例、恶性34例)的盆腔对比增强光谱CT,测量单能量图像衰减值、碘浓度及能谱斜率;动脉期与静脉期联合参数鉴别恶性与交界性肿瘤的敏感度80.8%、特异度82.4%、AUC 0.844。

要点

  • 动脉期和静脉期40–100 keV下,交界性肿瘤强化程度显著低于恶性上皮性卵巢肿瘤。
  • 动脉期与静脉期能谱斜率k值和碘浓度值在两组间均有显著差异。
  • 联合动脉期与静脉期参数鉴别恶性与交界性肿瘤的AUC为0.844。

核心结论

  • 双能光谱CT的多参数方法可用于鉴别交界性与恶性上皮性卵巢肿瘤,其中联合动脉期和静脉期图像参数诊断效能最佳。

研究设计与样本

  • 回顾性分析60例经组织病理学证实的卵巢上皮性肿瘤患者(交界性26例、恶性34例),均行盆腔对比增强光谱CT,在实性肿瘤成分上选取感兴趣区测量40–140 keV单能量图像各期衰减值及材料分解图像碘浓度。

关键影像表现/征象

  • 动脉期和静脉期40–100 keV下,交界性肿瘤强化程度显著低于恶性上皮性卵巢肿瘤(p<0.05)。
  • 动脉期和静脉期能谱斜率k值与碘浓度值在交界性与恶性组间均有显著差异(p<0.05)。

诊断标准与关键数值

  • 联合动脉期与静脉期对比增强图像参数鉴别恶性与交界性上皮性卵巢肿瘤:敏感度80.8%、特异度82.4%、AUC 0.844。
  • 能谱斜率k =(40 keV衰减值 − 140 keV衰减值)/100。

临床应用与阅片要点

  • 在实性肿瘤成分上选取感兴趣区,测量动脉期和静脉期40–140 keV单能量衰减值及碘浓度。
  • 计算能谱斜率k与碘浓度,并联合动脉期与静脉期参数用于鉴别交界性与恶性上皮性卵巢肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the value of contrast-enhanced dual-energy spectral computed tomography (CT) in differentiating borderline epithelial ovarian tumours (BEOTs) from malignant epithelial ovarian tumours (MEOTs).

MATERIALS AND METHODS: Sixty patients who underwent pelvic contrast-enhanced spectral CT were divided into two groups for analysis based on the tumour types confirmed at histopathological examination (26 BEOTs and 34 MEOTs). The regions of interest (ROIs) were selected on solid tumour components to measure attenuation values on monochromatic image sets (40-140 keV) in all imaging phases and tumour iodine concentrations (IC) on material decomposition images. Differences in the attenuation value between the unenhanced and contrast-enhanced phases (enhancement degree) and between energy strengths (slope k, k = [attenuation at 40 keV- attenuation at 140 keV]/100) were calculated. All measurements between the two groups were compared with independent t-test. Receiver operating characteristic (ROC) curves were generated to calculate the sensitivity, specificity and area under the ROC curve (AUC). Logistic regression analysis was used to evaluate the diagnostic efficacy of using combined parameters in two-phase contrast-enhanced images.

RESULTS: In the arterial phase (AP) and venous phase (VP), the BEOTs had significantly lower enhancement than MEOTs from 40 to 100 keV (p<0.05). The k values and IC values both showed significant differences in the AP and VP (p<0.05). Combining parameters in two contrast-enhanced phases provided 80.8% sensitivity and 82.4% specificity in differentiating MEOTs from BEOTs with an AUC of 0.844.

CONCLUSION: Dual-energy spectral CT provides a multiparametric approach in differentiating BEOTs from MEOTs with the best diagnostic efficacy using combined parameters in the AP and VP images.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Han X, Li B, Sun M, et al. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours. Clin Radiol. 2021. PMID: 34059294. doi:10.1016/j.crad.2021.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。